Dr Luis Furuya Kanamori

MBBS, MEpi, MPH, PhD
NHMRC Early Career Fellow

Biography

 

Luis finished his PhD at the RSPH under the supervision of Prof Archie Clements. He then spent two amazing years teaching and conducting research at the College of Medicine, Qatar University.

Luis has returned to the RSPH to start an NHMRC Early Career Fellowship under the supervision of Prof Martyn Kirk. He will make use of distinct approaches (primary data analysis, meta-analysis, and mathematical modelling) to assess the current and future risk of importation of multidrug resistant enterobacteriaceae into Australia and to design strategies to effectively mitigate those risks.

Luis’ research focuses on answering clinical epidemiological questions (mainly related to infectious diseases) through the analysis of primary data as well as the application of research synthesis methods. Luis has also interest on simulation studies and improving current meta-analytical methods, he has developed an index (LFK index) for detecting publication bias in meta-analysis which is fully implemented in MetaXL (www.epigear.com).

Publications

1. Furuya-Kanamori L, Walker RM, Gillespie BM, Clark J, Doi SAR, Thalib L. Effectiveness of different topical treatments in the healing of pressure injuries: A network meta-analysis. J Am Med Dir Assoc 2018; [Epub ahead of print]

2. Lau C, Ramsey L, Mills L, Furuya-Kanamori L, Mills D. Drug-free holidays: Compliance, tolerability, and acceptability of a 3-day atovaquone/proguanil schedule for pre-travel malaria chemoprophylaxis in Australian travellers. Clin Infect Dis 2018; [Epub ahead of print]

3. Furuya-Kanamori L, Barendregt JJ, Doi SA. A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc 2018; 16(4):195-203

4. Furuya-Kanamori L, Sedrakyan A, Onitilo AA, Bagheri N, Glasziou P, Doi SAR. Differentiated thyroid cancer: Millions spent with no tangible gain? Endocr Relat Cancer 2018; 25(1):51-7

5. Doi SAR, Furuya-Kanamori L, Thalib L, Barendregt JJ. Meta-analysis in health research: A paradigm shift is overdue. Int J Evid Based Healthc 2017; 15(4):152-60

6. Chen Y, Furuya-Kanamori L, Doi SA, Ananthakrishnan AN, Kirk M. Clostridium difficile infection and risk of colectomy in patients with inflammatory bowel disease: A bias adjusted meta-analysis. Inflamm Bowel Dis 2017; 23(2):200-7

7. Furuya-Kanamori L, Clements AC, Foster NF, Huber CA, Hong S, Harris-Brown T, Yakob L, Paterson DL, Riley TV. Asymptomatic Clostridium difficile colonisation in two Australian tertiary hospitals, 2012-2014: A prospective, repeated cross-sectional study. Clin Microb Infect 2017; 23(1):48.e1-7

8. Furuya-Kanamori L, Doi SA, Paterson DL, Helms SK, Yakob L, McKenzie SJ, Garborg K, Emanuelsson F, Stollman N, Kronman MP, Clark J, Huber CA, Riley TV, Clements AC. Upper versus lower-gastrointestinal delivery for transplantation of fecal microbiota in recurrent or refractory Clostridium difficile infection – A collaborative analysis of individual patient data from 14 studies. J Clin Gastroenterol 2017; 51(2):145-150

9. Furuya-Kanamori L, Bell KJL, Clark J, Glasziou P, Doi SA. Prevalence of differentiated thyroid cancer in autopsy studies over six decades: A Meta-analysis. J Clin Oncol 2016; 34:3672-9

10. Furuya-Kanamori L, Riley TV, Paterson DL, Foster NF, Huber CA, Hong S, Harris-Brown T, Robson J, Clements AC. Comparison of Clostridium difficile ribotypes circulating in Australian hospitals and communities. J Clin Microbiol 2016; 55(1):216-25